摘要
阿尔茨海默氏症(AD)是一种慢性神经退行性脑疾病,其特征是老年人的记忆障碍、痴呆和氧化应激。目前,市场上只有几种副作用。因此,为了开发具有对疾病有保护作用的新药,研究正转向鉴定植物产品作为一种补救药物。具有抗炎活性的天然化合物可能成为开发有效治疗策略的好候选药物。植物化学物质,包括姜黄素、白藜芦醇、槲皮素、胡培嗪a、迷迭香酸、染料木素、卵波瓦醇和奥氧维他醇,被报道为治疗AD的分子。一些生物碱,如甘兰他胺、冬冬苷、B、四山嘌呤、小檗碱和阿那他滨,已在体内AD模型和体内均显示出抗炎作用。总之,来自植物的天然产物是治疗AD的有趣的候选药物。本综述强调了天然产物中的特定化合物及其合成衍生物抵消中枢神经系统中AD的潜力。
关键词: 淀粉样前体蛋白黄酮类,阿尔茨海默病,BACE-1,小胶质细胞,天然产物,植物化学物质。
Current Medicinal Chemistry
Title:Natural Anti-inflammatory Compounds as Drug Candidates in Alzheimer’s Disease
Volume: 28 Issue: 23
关键词: 淀粉样前体蛋白黄酮类,阿尔茨海默病,BACE-1,小胶质细胞,天然产物,植物化学物质。
摘要: Alzheimer's disease (AD) is a chronic neurodegenerative brain disorder characterized by memory impairment, dementia, and oxidative stress in elderly people. Currently, only a few drugs are available in the market with various adverse effects. Therefore, to develop new drugs with protective action against the disease, research is turning to the identification of plant products as a remedy. Natural compounds with anti-inflammatory activity could be good candidates for developing effective therapeutic strategies. Phytochemicals, including Curcumin, Resveratrol, Quercetin, Huperzine-A, Rosmarinic acid, genistein, obovatol, and Oxyresvertarol, were reported molecules for the treatment of AD. Several alkaloids, such as galantamine, oridonin, glaucocalyxin B, tetrandrine, berberine and anatabine, have been shown anti-inflammatory effects in AD models in vitro as well as in-vivo. In conclusion, natural products from plants represent interesting candidates for the treatment of AD. This review highlights the potential of specific compounds from natural products along with their synthetic derivatives to counteract AD in the CNS.
Export Options
About this article
Cite this article as:
Natural Anti-inflammatory Compounds as Drug Candidates in Alzheimer’s Disease, Current Medicinal Chemistry 2021; 28 (23) . https://dx.doi.org/10.2174/0929867327666200730213215
DOI https://dx.doi.org/10.2174/0929867327666200730213215 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nanostructured Lipid Carriers (NLCs) for Drug Delivery: Role of Liquid Lipid (Oil)
Current Drug Delivery Methotrexate: A Drug of the Future in Ulcerative Colitis?
Current Drug Targets Supercritical Fluid Extraction of Bioactive Compounds from Botanic Matrices: Experimental Data, Process Parameters and Economic Evaluation
Recent Patents on Engineering Gemini Surfactant Based Carriers in Gene and Drug Delivery
Current Medicinal Chemistry Evidence-Based Percutaneous Closure of the Left Atrial Appendage in Patients with Atrial Fibrillation
Current Cardiology Reviews Contraindications for Anticoagulation in Older Patients with Atrial Fibrillation: A Narrative Review
Current Drug Safety Association Between Anemia and Dementia: A Nationwide, Populationbased Cohort Study in Taiwan
Current Alzheimer Research Dyslipidemia, Hypertension and Diabetes Metaflammation: A Unique Mechanism for 3 Risk Factors
Current Hypertension Reviews Review on Bosentan, A Dual Endothelin Receptor Antagonist for the Treatment of Pulmonary Arterial Hypertension
Recent Patents on Cardiovascular Drug Discovery The HLA Region and Autoimmune Disease: Associations and Mechanisms of Action
Current Genomics Enhanced Proinflammatory State and Autoimmune Activation: a Breakthrough to Understanding Chronic Diseases
Current Pharmaceutical Design Mast Cells: Target and Source of Neuropeptides
Current Pharmaceutical Design Apoptotic Regulators and RA
Current Rheumatology Reviews Possible Mechanisms of Lymphoma Development in Sjogren’s Syndrome
Current Immunology Reviews (Discontinued) Oxidative Stress and the Use of Antioxidants for the Treatment of Rheumatoid Arthritis
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Atherosclerotic and Non-Atherosclerotic Coronary Heart Disease in Women
Current Medicinal Chemistry The Common Mycobacterial Antigens and their Importance in the Treatment of Disease
Current Pharmaceutical Design Ketamine for Chronic Pain and Treatment Resistant Depression: A Mechanistic Hypothesis
Current Drug Therapy Resveratrol as a Chemopreventive Agent: A Promising Molecule for Fighting Cancer
Current Drug Targets Relevance of Nutritional Antioxidants in Metabolic Syndrome, Ageing and Cancer: Potential for Therapeutic Targeting
Infectious Disorders - Drug Targets